EP 1545708 A2 20050629 - HETEROCYCLIC COMPOUND FOR STIMULATING OR INDUCING HAIR OR EYELASH GROWTH AND/OR FOR SLOWING DOWN HAIR LOSS, COMPOSITION CONTAINING SAME, AND USES THEREOF
Title (en)
HETEROCYCLIC COMPOUND FOR STIMULATING OR INDUCING HAIR OR EYELASH GROWTH AND/OR FOR SLOWING DOWN HAIR LOSS, COMPOSITION CONTAINING SAME, AND USES THEREOF
Title (de)
HETEROCYCLISCHE VERBINDUNG ZUR STIMULIERUNG ODER INDUZIERUNG DES HAAR- ODER WIMPERNWACHSTUMS UND/ODER ZUR VERLANGSAMUNG DES HAARAUSFALLS, DIESE ENTHALTENDE ZUSAMMENSETZUNG UND IHRE VERWENDUNGEN
Title (fr)
COMPOSE HETEROCYCLIQUE POUR STIMULER OU INDUIRE LA POUSSE DES CHEVEUX OU DES CILS ET/OU FREINER LEUR CHUTE, COMPOSITION LE CONTENANT, SES UTILISATIONS
Publication
Application
Priority
- FR 0302823 W 20030925
- FR 0212018 A 20020927
Abstract (en)
[origin: FR2845000A1] The use of 2-(heterocyclylidene-methyl)-5-phenyl-furan, thiophene or pyrrole compounds (I) for inducing and/or stimulating the growth, inhibiting the loss and/or increasing the density of (preferably human) keratin fibers and/or for inhibiting (preferably human) 15-hydroxy-prostaglandin dehydrogenase is new. The use of heterocyclic compounds of formula (I) or their salts is claimed as agents for inducing and/or stimulating the growth, inhibiting the loss and/or increasing the density of (preferably human) keratin fibers and/or for inhibiting (preferably human) 15-hydroxy-prostaglandin dehydrogenase (15-PGDH). Hy = 4-7 membered heterocycle, optionally containing at least one =O and/or =S function and optionally substituted (os) by one or more groups Q; Q = halo, OR, SR, NRR', COR, CSR, NRCONR'R'', C(=NR)R', OCOR, COSR, SCOR, CSNRR', NRCSR',NRCSNR'R'', COOR, CONRR', CF3, CN, NRCOR', SO2R', SO2NRR', NRSO2R', optionally unsaturated, os 1-20C alkyl or os, saturated or unsaturated 4-7 membered ring (optionally fused and/or containing heteroatom(s)); R, R', R'', R''' = H, 1-20C alkyl or os acyl; G = O, S or N; R1, R2, R3 = H, NO2 or Q.
IPC 1-7
A61P 17/14; A61K 7/06; C07D 417/06; C07D 413/06; C07D 405/06; C07D 409/06
IPC 8 full level
A61K 8/49 (2006.01); A61K 31/427 (2006.01); A61K 35/36 (2015.01); A61P 17/14 (2006.01); A61Q 7/00 (2006.01); C07D 417/06 (2006.01)
CPC (source: EP KR US)
A61K 8/49 (2013.01 - EP US); A61K 8/4913 (2013.01 - EP US); A61K 8/4986 (2013.01 - EP US); A61K 31/427 (2013.01 - EP US); A61K 35/36 (2013.01 - EP US); A61P 17/14 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61Q 7/00 (2013.01 - EP US); C07D 417/06 (2013.01 - EP KR US); A61K 2800/782 (2013.01 - EP US)
Citation (search report)
See references of WO 2004028441A2
Citation (examination)
WO 2004073594 A2 20040902 - OREAL [FR], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2845000 A1 20040402; FR 2845000 B1 20050527; AU 2003299068 A1 20040419; AU 2003299068 B2 20080605; BR 0314490 A 20050802; CA 2499689 A1 20040408; CN 1703259 A 20051130; EP 1545708 A2 20050629; JP 2006518338 A 20060810; KR 20050067397 A 20050701; MX PA05003126 A 20060309; RU 2005112734 A 20060227; RU 2316325 C2 20080210; US 2006008436 A1 20060112; US 2008076809 A1 20080327; US 7294641 B2 20071113; WO 2004028441 A2 20040408; WO 2004028441 A3 20040506; WO 2004028441 A8 20070118
DOCDB simple family (application)
FR 0212018 A 20020927; AU 2003299068 A 20030925; BR 0314490 A 20030925; CA 2499689 A 20030925; CN 03825452 A 20030925; EP 03798227 A 20030925; FR 0302823 W 20030925; JP 2005501926 A 20030925; KR 20057005150 A 20050325; MX PA05003126 A 20030925; RU 2005112734 A 20030925; US 67150803 A 20030929; US 90286407 A 20070926